newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

Conference Call to be held Tuesday, July 26th at 4:30pm ET NEW YORK, July 26, 2022 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative